SCHEMBL710351

SCHEMBL710351

Cc1ccc(CN(Cc2ccc(C)cc2)c2nccc(-c3ccc(-c4ccc(N(c5ccccc5)c5ccccc5)cc4)cc3)n2)cc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2C19 P33261 1/20 0.46
CTSK P43235 1/20 0.44
CYP19A1 P11511 1/20 0.40
CYP11B1 P15538 1/20 0.39
CNR2 P34972 4/20 0.39
CNR1 P21554 3/20 0.39
SREBF2 Q12772 2/20 0.38
MEN1 O00255 2/20 0.38
KMT2A Q03164 2/20 0.38
TSHR P16473 1/20 0.37
PDK1 Q15118 1/20 0.36
PTGES O14684 1/20 0.36
ALOX5 P09917 1/20 0.36
LTB4R2 Q9NPC1 1/20 0.36
QPCT Q16769 1/20 0.36
SREBF1 P36956 1/20 0.35
HTT P42858 1/20 0.35
ESR1 P03372 1/20 0.35
ESR2 Q92731 1/20 0.35
TAAR1 Q96RJ0 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL709817 0.91 CTSK (0.43) CYP2C19CTSKCYP11B1CNR2KMT2A
SCHEMBL708348 0.87 LMNA (0.45) CYP2C19CTSKCYP19A1CNR2CNR1
SCHEMBL708351 0.77 DYRK1A (0.48) MEN1KMT2A
SCHEMBL10019585 0.76 DYRK1A (0.49) CYP2C19CYP11B1MEN1KMT2ATSHR
SCHEMBL10019584 0.75 DYRK1A (0.48) CYP2C19CYP11B1MEN1KMT2ATSHR
SCHEMBL12799477 0.72 CYP2C19 (0.47) CYP2C19CYP19A1CNR2CNR1MEN1
SCHEMBL12799469 0.72 CYP2C19 (0.47) CYP2C19CYP19A1CNR2CNR1MEN1
SCHEMBL12799483 0.72 CYP2C19 (0.47) CYP2C19CYP19A1CNR2CNR1MEN1
SCHEMBL21655106 0.72 CYP2C19 (0.47) CYP2C19CYP19A1CNR2CNR1MEN1
SCHEMBL15070947 0.72 CYP2C19 (0.47) CYP2C19CYP19A1CNR2CNR1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8124762-B2 Diphenyl amine derivatives having luminescence property KOREA INSTITUTE OF SCIENCE & TECHNOLOGY (KR) 2012-02-28 US disclosed
US-8124762-B2 Diphenyl amine derivatives having luminescence property KOREA INSTITUTE OF SCIENCE & TECHNOLOGY (KR) 2012-02-28 US disclosed
US-8124762-B2 Diphenyl amine derivatives having luminescence property KOREA INSTITUTE OF SCIENCE & TECHNOLOGY (KR) 2012-02-28 US disclosed
US-20100063281-A1 DIPHENYL AMINE DERIVATIVES HAVING LUMINESCENCE PROPERTY KOREA INSTITUTE OF SCIENCE & TECHNOLOGY (KR) 2010-03-11 US disclosed
US-20100063281-A1 DIPHENYL AMINE DERIVATIVES HAVING LUMINESCENCE PROPERTY KOREA INSTITUTE OF SCIENCE & TECHNOLOGY (KR) 2010-03-11 US disclosed
US-20100063281-A1 DIPHENYL AMINE DERIVATIVES HAVING LUMINESCENCE PROPERTY KOREA INSTITUTE OF SCIENCE & TECHNOLOGY (KR) 2010-03-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100063281-A1 DIPHENYL AMINE DERIVATIVES HAVING LUMINESCENCE PROPERTY TYR, PNMT, DDC CYP2C19 559/4885CTSK 4010/4885CYP19A1 2322/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.